Company Profile:
DR REDDY S. LABORATORIES S.A. in the Philippines is primarily a Trading and Distribution Company.
Company Introduction:
Dr. Reddy's Laboratories S.A. in the Philippines operates as a key subsidiary of Dr. Reddy's Laboratories Ltd., a multinational pharmaceutical company headquartered in India. Its main function in the Philippine market is the marketing, sales, and distribution of a comprehensive portfolio of pharmaceutical products.
The company focuses on providing access to a wide range of high-quality, affordable medicines, including generic and branded prescription drugs, over-the-counter (OTC) products, and biosimilars. Their therapeutic areas cover critical segments such as oncology, cardiology, diabetes, gastroenterology, pain management, and more.
While the parent company, Dr. Reddy's Laboratories Ltd., is a global manufacturer with extensive research and development capabilities and manufacturing facilities worldwide, the Philippine entity primarily serves as the commercial arm, ensuring that these essential medicines reach patients and healthcare providers across the archipelago. Dr. Reddy's Laboratories S.A. is committed to improving health outcomes in the Philippines by making innovative and established therapies accessible.
Enterprise Products
Dr. Reddy's Laboratories S.A. in the Philippines manufactures or sells products primarily across the following therapeutic areas:
Cardiovascular
Diabetes
Gastroenterology
Oncology
Pain Management
Dermatology
Central Nervous System
Infectious Diseases
Nutraceuticals
Their product portfolio generally includes:
Statins for cholesterol management
Antidiabetic medications
Proton pump inhibitors for acid-related disorders
Analgesics and anti-inflammatory drugs
Antibiotics
Antifungal medications
Dermatological creams and ointments
Various generic oncology drugs
Nutritional supplements and vitamins
Antihistamines
Antidepressants and anxiolytics